Drug information for PARICALCITOL

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 1MCG Tentative Approval   PARICALCITOL paricalcitol TEVA PHARMS 90829
2010-08-26 Letter
CAPSULE; ORAL 2MCG Tentative Approval   PARICALCITOL paricalcitol TEVA PHARMS   "
CAPSULE; ORAL 4MCG Tentative Approval   PARICALCITOL paricalcitol TEVA PHARMS   "
CAPSULE; ORAL 1MCG Tentative Approval   PARICALCITOL paricalcitol DR REDDYS LABS LTD 91412
CAPSULE; ORAL 2MCG Tentative Approval   PARICALCITOL paricalcitol DR REDDYS LABS LTD   "
CAPSULE; ORAL 4MCG Tentative Approval   PARICALCITOL paricalcitol DR REDDYS LABS LTD   "
INJECTABLE; INJECTION 0.002MG/ML Prescription AP  PARICALCITOL paricalcitol SANDOZ CANADA INC 91108
2011-07-29 Letter
INJECTABLE; INJECTION 0.005MG/ML Prescription AP  PARICALCITOL paricalcitol SANDOZ CANADA INC   "

Drug Adverse Effects information for PARICALCITOL

Role code Indications Reaction # Reports
PS HYPERPARATHYROIDISM SECONDARY CORONARY ARTERY DISEASE 2
PS HYPERPARATHYROIDISM SECONDARY DIZZINESS 2
PS HYPERPARATHYROIDISM SECONDARY DYSPNOEA 2
PS HYPERPARATHYROIDISM SECONDARY NEOPLASM SKIN 1
PS HYPERPARATHYROIDISM SECONDARY POST PROCEDURAL INFECTION 1
PS HYPERPARATHYROIDISM SECONDARY VOMITING 2
PS PRODUCT USED FOR UNKNOWN INDICATION CORONARY ARTERY DISEASE 12
PS PRODUCT USED FOR UNKNOWN INDICATION DIZZINESS 12
PS PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 12
PS PRODUCT USED FOR UNKNOWN INDICATION NEOPLASM SKIN 2
PS PRODUCT USED FOR UNKNOWN INDICATION PARATHYROIDECTOMY 7
PS PRODUCT USED FOR UNKNOWN INDICATION POST PROCEDURAL INFECTION 2
PS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 12
PS RENAL FAILURE CHRONIC CORONARY ARTERY DISEASE 1
PS RENAL FAILURE CHRONIC DIZZINESS 1
PS RENAL FAILURE CHRONIC DYSPNOEA 1
PS RENAL FAILURE CHRONIC VOMITING 1
SS HYPERPARATHYROIDISM SECONDARY NEOPLASM SKIN 4
SS HYPERPARATHYROIDISM SECONDARY POST PROCEDURAL INFECTION 4
SS PRODUCT USED FOR UNKNOWN INDICATION NEOPLASM SKIN 8
SS PRODUCT USED FOR UNKNOWN INDICATION POST PROCEDURAL INFECTION 8
C NEPHROGENIC ANAEMIA ANGINA PECTORIS 6
C NEPHROGENIC ANAEMIA ATRIAL FIBRILLATION 4
C NEPHROGENIC ANAEMIA ATRIAL FLUTTER 2
C NEPHROGENIC ANAEMIA BRONCHOPNEUMONIA 2
C NEPHROGENIC ANAEMIA CEREBRAL ATROPHY 2
C NEPHROGENIC ANAEMIA CEREBRAL ISCHAEMIA 6
C NEPHROGENIC ANAEMIA CEREBROVASCULAR ACCIDENT 2
C NEPHROGENIC ANAEMIA CHRONIC MYELOID LEUKAEMIA 6
C NEPHROGENIC ANAEMIA CONFUSIONAL STATE 4
C NEPHROGENIC ANAEMIA DELIRIUM 4
C NEPHROGENIC ANAEMIA FALL 2
C NEPHROGENIC ANAEMIA HAEMOGLOBIN DECREASED 4
C NEPHROGENIC ANAEMIA HEART RATE INCREASED 2
C NEPHROGENIC ANAEMIA HEART VALVE CALCIFICATION 2
C NEPHROGENIC ANAEMIA HYPERTENSION 2
C NEPHROGENIC ANAEMIA IN-STENT CORONARY ARTERY RESTENOSIS 4
C NEPHROGENIC ANAEMIA LETHARGY 4
C NEPHROGENIC ANAEMIA MYOCARDIAL INFARCTION 6
C NEPHROGENIC ANAEMIA MYOCARDIAL ISCHAEMIA 6
C NEPHROGENIC ANAEMIA OSTEOPOROSIS 2
C NEPHROGENIC ANAEMIA SPINAL COMPRESSION FRACTURE 6
C NEPHROGENIC ANAEMIA SUDDEN DEATH 2
C NEPHROGENIC ANAEMIA WRONG DRUG ADMINISTERED 2
C NUCLEAR MAGNETIC RESONANCE IMAGING GAIT DISTURBANCE 3
C NUCLEAR MAGNETIC RESONANCE IMAGING LOCALISED OEDEMA 3
C NUCLEAR MAGNETIC RESONANCE IMAGING MUSCULOSKELETAL STIFFNESS 3
C NUCLEAR MAGNETIC RESONANCE IMAGING NEPHROGENIC SYSTEMIC FIBROSIS 3
C NUCLEAR MAGNETIC RESONANCE IMAGING PAIN 3
C NUCLEAR MAGNETIC RESONANCE IMAGING PAIN IN EXTREMITY 3
C NUCLEAR MAGNETIC RESONANCE IMAGING RASH MACULAR 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN FIBROSIS 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN HYPERPIGMENTATION 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN HYPERTROPHY 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN INDURATION 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN PLAQUE 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN TIGHTNESS 3
C OSTEOPOROSIS HYPOCALCAEMIA 1
C OSTEOPOROSIS PALPITATIONS 1
C OSTEOPOROSIS PARAESTHESIA 1
Ads by Google